Published in Mol Cell Biol on June 21, 2010
Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.). Br J Haematol (2013) 2.33
Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros. Nat Immunol (2013) 1.88
A role for IRF4 in the development of CLL. Blood (2013) 1.54
CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL. Blood (2015) 1.51
Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia. Am J Blood Res (2013) 1.33
Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros. Proc Natl Acad Sci U S A (2012) 1.30
Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling. Nat Rev Immunol (2013) 1.18
Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. Blood (2011) 1.12
Ikaros and tumor suppression in acute lymphoblastic leukemia. Crit Rev Oncog (2011) 1.01
Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia. Front Oncol (2014) 0.97
FoxO1 induces Ikaros splicing to promote immunoglobulin gene recombination. J Exp Med (2012) 0.97
Ikaros is absolutely required for pre-B cell differentiation by attenuating IL-7 signals. J Exp Med (2013) 0.95
IRF4 is a suppressor of c-Myc induced B cell leukemia. PLoS One (2011) 0.95
Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4. Blood Cancer J (2015) 0.91
Signaling proteins and transcription factors in normal and malignant early B cell development. Bone Marrow Res (2011) 0.89
Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response. Genes Immun (2012) 0.87
Lymphocyte development: integration of DNA damage response signaling. Adv Immunol (2012) 0.87
The Igκ gene enhancers, E3' and Ed, are essential for triggering transcription. J Immunol (2010) 0.86
Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia. Oncotarget (2015) 0.84
The immunogenetics of primary biliary cirrhosis: A comprehensive review. J Autoimmun (2015) 0.83
Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia. Leukemia (2015) 0.83
A role for IRF8 in B cell anergy. J Immunol (2013) 0.82
Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc/p53-dependent bottleneck in lymphomagenesis. PLoS Genet (2014) 0.81
Cutting edge: cell-autonomous control of IL-7 response revealed in a novel stage of precursor B cells. J Immunol (2013) 0.80
Gpr97 is essential for the follicular versus marginal zone B-lymphocyte fate decision. Cell Death Dis (2013) 0.79
Novel mechanism of tumor suppression by polarity gene discs large 1 (DLG1) revealed in a murine model of pediatric B-ALL. Cancer Immunol Res (2013) 0.79
IRF4 and IRF8: Governing the virtues of B Lymphocytes. Front Biol (Beijing) (2014) 0.79
PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia. Leukemia (2016) 0.78
A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma. Mod Pathol (2016) 0.78
Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells. J Virol (2014) 0.78
A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells. Stem Cell Reports (2014) 0.78
Balancing Proliferation with Igκ Recombination during B-lymphopoiesis. Front Immunol (2014) 0.77
A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders. PLoS One (2013) 0.77
Microarray Analysis of Gene Expression Reveals that Cyclo-oxygenase-2 Gene Therapy Up-regulates Hematopoiesis and Down-regulates Inflammation During Endochondral Bone Fracture Healing. J Bone Metab (2014) 0.75
The Ikaros family of zinc-finger proteins. Acta Pharm Sin B (2016) 0.75
A high-resolution map of transcriptional repression. Elife (2017) 0.75
Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. Blood (2017) 0.75
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med (2009) 10.54
A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell (1996) 8.41
The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol (2008) 6.60
Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity (1999) 5.50
Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity (2001) 4.09
A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell (2007) 3.81
The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. J Exp Med (1988) 3.80
N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev (2000) 3.62
Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J (1996) 3.18
The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol (1994) 3.15
Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat Rev Immunol (2002) 2.76
Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling. Immunity (2008) 2.72
Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J (1997) 2.71
Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity (2007) 2.65
Aiolos regulates B cell activation and maturation to effector state. Immunity (1998) 2.24
Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol (2009) 2.19
Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion. Immunity (2008) 2.16
IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev (2003) 2.12
The c-myc promoter: still MysterY and challenge. Adv Cancer Res (2008) 2.06
Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene (2001) 2.05
Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. J Exp Med (2000) 1.92
Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression. Genes Dev (2000) 1.87
Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function. J Exp Med (2009) 1.80
IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development. J Immunol (2006) 1.72
Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway. Immunity (2001) 1.71
A unique function for cyclin D3 in early B cell development. Nat Immunol (2006) 1.51
Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development. Nat Immunol (2009) 1.48
Molecular requirements for transcriptional initiation of the murine c-myc gene. Oncogene (1989) 1.43
Interferon regulatory factor 4 and 8 in B-cell development. Trends Immunol (2008) 1.41
Myc stimulates B lymphocyte differentiation and amplifies calcium signaling. J Cell Biol (2007) 1.29
Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor. Immunity (2007) 1.17
Ikaros-family proteins: in search of molecular functions during lymphocyte development. Curr Top Microbiol Immunol (2005) 1.16
Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation. Mol Cell Biol (2004) 1.13
Interleukin-7 induces N-myc and c-myc expression in normal precursor B lymphocytes. Genes Dev (1992) 1.12
A role for interferon regulatory factor 4 in receptor editing. Mol Cell Biol (2008) 0.96
Generation of normal lymphocytes derived from N-myc-deficient embryonic stem cells. Int Immunol (1995) 0.92
TATA box and Sp1 sites mediate the activation of c-myc promoter P1 by immunoglobulin kappa enhancers. Gene Expr (1996) 0.82
Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem (2003) 4.33
Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat Med (2006) 2.35
HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse. Immunity (2006) 2.23
Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia. Blood (2014) 1.95
B cell antigen receptor signaling and internalization are mutually exclusive events. PLoS Biol (2006) 1.85
Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes. Leuk Lymphoma (2014) 1.77
IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development. J Immunol (2006) 1.72
Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2. Nat Immunol (2011) 1.59
A role for IRF4 in the development of CLL. Blood (2013) 1.54
Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res (Hoboken) (2011) 1.54
In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J Immunol (2010) 1.54
A unique function for cyclin D3 in early B cell development. Nat Immunol (2006) 1.51
Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development. Nat Immunol (2009) 1.48
Regulation of T-cell progenitor survival and cell-cycle entry by the pre-T-cell receptor. Immunol Rev (2006) 1.45
Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem (2002) 1.33
Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial. J Rheumatol (2002) 1.28
Hedgehog signaling controls thymocyte progenitor homeostasis and differentiation in the thymus. Nat Immunol (2006) 1.28
The direct recruitment of BLNK to immunoglobulin alpha couples the B-cell antigen receptor to distal signaling pathways. Mol Cell Biol (2002) 1.20
Critical role of IRF-5 in regulation of B-cell differentiation. Proc Natl Acad Sci U S A (2010) 1.19
A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation. Nat Immunol (2012) 1.18
Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci Transl Med (2014) 1.14
Ubiquitinylation of Ig beta dictates the endocytic fate of the B cell antigen receptor. J Immunol (2007) 1.09
Endocytic sequestration of the B cell antigen receptor and toll-like receptor 9 in anergic cells. Proc Natl Acad Sci U S A (2009) 1.06
Receptor-facilitated antigen presentation requires the recruitment of B cell linker protein to Igalpha. J Immunol (2002) 1.02
B-cell antigen-receptor signalling in lymphocyte development. Immunology (2003) 0.99
A role for interferon regulatory factor 4 in receptor editing. Mol Cell Biol (2008) 0.96
IRF4 is a suppressor of c-Myc induced B cell leukemia. PLoS One (2011) 0.95
Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients. Ann Surg Oncol (2014) 0.94
Regulation of lymphocyte progenitor survival by the proapoptotic activities of Bim and Bid. Proc Natl Acad Sci U S A (2008) 0.92
Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis. Arthritis Rheumatol (2014) 0.91
The emerging role of the inflammasome in kidney diseases. Curr Opin Nephrol Hypertens (2014) 0.89
Germinal center B-cells. Autoimmunity (2012) 0.89
Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4. J Biol Chem (2013) 0.88
Statin and aspirin use is associated with improved outcome of FCR therapy in relapsed/refractory chronic lymphocytic leukemia. Blood (2014) 0.87
Flippin' lipids. Nat Immunol (2011) 0.87
Beta-catenin/Tcf determines the outcome of thymic selection in response to alphabetaTCR signaling. J Immunol (2009) 0.86
Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid. Arthritis Rheumatol (2014) 0.83
Spi-1 and Spi-B control the expression of the Grap2 gene in B cells. Gene (2005) 0.83
Structure and evolutionary aspects of matrix metalloproteinases: a brief overview. Mol Cell Biochem (2003) 0.83
A point mutation in the constant region of Ig lambda1 prevents normal B cell development due to defective BCR signaling. Immunity (2002) 0.82
A role for IRF8 in B cell anergy. J Immunol (2013) 0.82
Subnuclear cyclin D3 compartments and the coordinated regulation of proliferation and immunoglobulin variable gene repression. J Exp Med (2012) 0.80
Cooperative interaction of Ig(alpha) and Ig(beta) of the BCR regulates the kinetics and specificity of antigen targeting. Int Immunol (2002) 0.80
Selection of B lymphocytes in the periphery is determined by the functional capacity of the B cell antigen receptor. Proc Natl Acad Sci U S A (2004) 0.77
Membrane-targeted peptides derived from Igalpha attenuate B-cell antigen receptor function. Biochem Biophys Res Commun (2004) 0.77
Identification, purification and characterization of matrix metalloproteinase-2 in bovine pulmonary artery smooth muscle plasma membrane. Mol Cell Biochem (2004) 0.76
Isolation of MMP-2 from MMP-2/TIMP-2 complex: characterization of the complex and the free enzyme in pulmonary vascular smooth muscle plasma membrane. Biochim Biophys Acta (2004) 0.76
Role of membrane-associated Ca+ dependent matrix metalloprotease-2 in the oxidant activation of Ca2+Atpase by tertiary butylhydroperoxide. Mol Cell Biochem (2002) 0.76
Overview of pathophysiology and treatment of human lupus nephritis. Curr Opin Rheumatol (2016) 0.75
Role of Ca2+-dependent metalloprotease-2 in stimulating Ca2+ ATPase activity under peroxynitrite treatment in bovine pulmonary artery smooth muscle membrane. IUBMB Life (2002) 0.75